Ginkgo Bioworks Holdings, Inc.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $84.5M | $143.9M | $167.2M | $111.1M | $203.6M | $312.4M | $561.6M | $616.2M |
| Accounts Receivable | $13.0M | $19.8M | $24.0M | $21.4M | $22.2M | $26.3M | $21.9M | $23.4M |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $332.5M | $410.0M | $471.8M | $506.1M | $523.0M | $564.5M | $602.7M | $662.5M |
| Property, Plant & Equipment | $157.2M | $163.0M | $167.4M | $176.6M | $186.4M | $197.8M | $203.7M | $211.0M |
| Goodwill | — | — | — | — | — | — | $0 | $0 |
| Intangible Assets (Excl. Goodwill) | $44.4M | $48.9M | $53.5M | $61.5M | $66.2M | $68.8M | $72.5M | $79.6M |
| Total Assets | $990.0M | $1.03B | $1.12B | $1.19B | $1.23B | $1.29B | $1.38B | $1.48B |
| Liabilities | ||||||||
| Accounts Payable | $9.6M | $16.3M | $10.6M | $10.7M | $11.2M | $11.3M | $14.2M | $15.7M |
| Total Current Liabilities | $72.7M | $79.6M | $96.0M | $115.3M | $96.7M | $115.7M | $107.3M | $114.4M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $569.8M | $589.9M | $611.1M | $629.4M | $618.1M | $646.0M | $661.4M | $682.9M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-6.28B | $-6.23B | $-6.15B | $-6.07B | $-5.99B | $-5.93B | $-5.84B | $-5.73B |
| Total Stockholders' Equity | $420.3M | $443.2M | $508.6M | $559.8M | $613.0M | $647.4M | $716.1M | $797.9M |